Wonder how much of this push is related to the Cubist deal. If Cubicin is 80% of their revs then the drug is worth roughly $6B today up 35% from Friday. This price discovery for new antibiotics is now cascading to CTIX. And if ours is truly better then sky is the limit!
Market Data 
Markets 
AI
